• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 14 - Concerns about Rising Costs of Treatment

Video

During this segment, the panelists discuss their concerns about the rising costs of drugs currently available to treat multiple sclerosis (MS).

Gary M. Owens, MD, states that it is unclear why drug prices continue to rise, especially when certain options have been available for years. Dr Owens further explains there is no single formula to determine a return on investment for newer agents.

Because the drugs to treat MS are extremely expensive and difficult for patients to afford, Dr Owens and Leslie Fish, PharmD, suggest that when reviewing and negotiating the price of a therapy option, there is a need for transparency and comparative effectiveness.


Related Videos
Laxmi Patel screenshot by AJMC
Refat Rasul Srejon, MPH
Refat Rasul Srejon, MPH
Refat Rasul Srejon, MPH
Screenshot of an interview with Nicolas Girard, MD, PhD
Byoung Chul Cho, MD, PhD
Beth Stein, MD, and Ratna Kiran Bhavaraju-Sanka, MD
© 2025 MJH Life Sciences
AJMC®
All rights reserved.